Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

BioNJ Gala on February 2 to Highlight Success Stories of NJ’s Flourishing Life Sciences Community

1/20/2017

0 Comments

 
Trenton, NJ — Representatives from the New Jersey Economic Development Authority (EDA) will join more than 750 biotechnology and pharmaceutical professionals, other government officials, academic leaders, and service providers on Feb. 2 at BioNJ's 24th Annual Gateway Gala & Innovation Celebration.
 
Entrepreneurs from three EDA-supported companies are among those who will be recognized during the gala. Celator Pharmaceuticals former Chief Executive Officer (CEO) Scott Jackson, Amicus Therapeutics Chairman of the Board and CEO John Crowley, and Chromocell CEO Christian Kopfli will receive BioNJ’s Innovator Award in the leadership category.
 
The gala will also highlight New Jersey’s many success stories of 2016 and give trade organization BioNJ the opportunity to tout why innovators choose to grow their companies in New Jersey.
 
According to BioNJ, the Garden State boasts the world’s highest concentration of scientists and engineers per square mile – more than 225,000 statewide.
​New Jersey is home to 14 of the world’s 20 largest biopharmaceutical companies, including Merck, Johnson & Johnson, and Pfizer, and 12 of the world’s top 22 research and development companies.
 
The annual economic impact of the industry in New Jersey is estimated to be $36 billion.
More than 64,210 individuals are employed in New Jersey’s life sciences industry.
 
BioNJ’s mission is to propel New Jersey’s robust life sciences ecosystem forward to accelerate the discovery, development and commercialization of therapies and cures for the patients who need them.
 
With more than 400 member companies, ranging from startups to large corporations, BioNJ has been an advocate for New Jersey’s life science community for over 20 years.
 
“As New Jersey’s life sciences presence continues to grow, BioNJ works to advance economic development through leadership and lobbying to develop programs and financial resources that will enrich an already vibrant life sciences landscape,” BioNJ President and CEO Debbie Hart said.
 
Member companies can take advantage of a multitude of BioNJ resources:
 
BioNJ’s Talent Services connects entrepreneurs with capable employees who can fit their staffing needs. The service offers candidate sourcing, human resources expertise, and career coaching and training.
 
BioNJ also offers an array of services and resources aimed at supporting member companies throughout their lifecycle. These include increased visibility on BioNJ’s website, LinkedIn page and weekly BioLines Weekender newsletter, as well as emerging company spotlight profiles and sponsorship opportunities.
 
Peer-to-peer networking and educational events such as exclusive forums, roundtable discussions, and participation in various BioNJ committees enable entrepreneurs to learn more about themselves, their community, and their industry.
 
BioNJ also holds an annual CEO Summit, which brings together the heads of innovator companies to discuss topics relevant to leaders in the life sciences sector.
 
“New Jersey has a dynamic life sciences community through which emerging entrepreneurs receive invaluable guidance from established entities, more-seasoned innovators, and giants in the pharmaceutical world,” EDA CEO Melissa Orsen. “It’s through organizations like BioNJ that these relationships are cultivated and strengthened.”
 
To register for BioNJ's 24th Annual Gateway Gala & Innovation Celebration, of which the EDA is a sponsor, visit http://bionj.org/event/2017-annual-gateway-gala-dinner.
 
The CEOs of two EDA-supported companies weighed in on the benefits of BioNJ membership:
 
TAXIS Pharmaceuticals, a Rutgers University spinout that graduated from the EDA’s Commercialization Center for Innovative Technologies, seeks to discover and develop pharmaceuticals targeting multidrug-resistant bacterial infections.
 
Taxis President and CEO Greg Mario, whose company also participated in the State’s Angel Investor Tax Credit Program, had this to say about BioNJ:
 
“Membership in BioNJ has provided us with access to tremendous resources,” Mario said.  “At different stages of our development, there were different resources. Starting out, it was really networking, meeting people. We hired people we met through relationships established at many of the meetings. And more recently we have accessed discounted chemicals and supplies to support our antibiotic drug development program.”
 
Agile Therapeutics is a specialty pharmaceutical company in Princeton that focuses on the development of innovative women’s healthcare products.
 
The company has repeatedly benefited from the State’s Technology Business Tax Certificate Transfer (NOL) Program. Agile Therapeutics President and CEO Al Altomari touts the many benefits that the organization provides:
 
“First, on an ongoing basis we get a lot of programming and introductions, things like the CEO Summit where we get a chance to collaborate with our peers,” Altomari said.
 
“In the long time that BioNJ has been our advocate, my company has received a lot of funding through the State’s NOL Program. In short, we’ve received a ton of benefits from our relationship with BioNJ and the State of New Jersey.”
 
Video of Mario, Altomari, and additional entrepreneurs touting the benefits of BioNJ membership can be found at http://www.njeda.com/bionjfeature.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507